Cognizant Expands AI-Enabled DevOps Capabilities for Gilead Sciences
Five-year agreement will support selected Gilead technology programs TEANECK, N.J., Oct. 6, 2026 /PRNewswire/ -- Cognizant announced a five-year extension of its work with Gilead Sciences, a biopharmaceutical company that has pursued and achieved breakthroughs in medicine for more than...
Short extract only — this publisher licenses its text. Read the full release at the source.
Cancel anytime · CA$99/month


